Dr. Timothy Scott Neavin, MD

Dr. Neavin practices at Adventist Health White Memorial in Los Angeles, California, part of Adventist Health.

Dr. Neavin's NPI, 1285899948, was assigned on July 22, 2008. Dr. Neavin graduated from Sidney Kimmel Medical College in 2002. Dr. Neavin holds California license A99678.

Dr. Neavin's primary practice is Adventist Health White Memorial, at 1720 Cesar E Chavez Avenue, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 268-5000.

Dr. Neavin's primary practice is Adventist Health White Memorial in Los Angeles, California, part of Adventist Health. Dmand AI also links Dr. Neavin to 1 physician office and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Neavin practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Neavin's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Neavin is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Neavin's licenses on file in 3 states: California, Nevada and Pennsylvania.

Dmand AI lists chronic skin ulcer among the conditions Dr. Neavin treats.

CMS data shows 174 Medicare services from Dr. Neavin across 7 procedure codes in 2024, for 82 Medicare patients. Medicare paid $19,911 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 82 Medicare patients who saw Dr. Neavin in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 43% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Neavin's median patient age at 62, with 35% women.

In 2024, Dr. Neavin wrote 62 Medicare Part D claims for 31 patients. 87% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $237 in total drug cost. In 2022, CMS named 24 claims across 2 drugs.

Dr. Neavin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 97 procedures of removal of tissue by Dr. Neavin, more than 85% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Neavin. Dr. Neavin's most frequent co-author is Wei-Ping Andrew Lee, MD.

CMS Open Payments shows 210 general payments to Dr. Neavin from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Smith & Nephew, Inc. paid the most, $3,272.

Dmand AI lists 1 award for Dr. Neavin, most recently Regional Top Doctor in 2014.

Dr. Neavin graduated from Sidney Kimmel Medical College in 2002. Dr. Neavin is a member of ASPS.

Dr. Neavin is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.